NORTHERN TRUST CORP - SUMMIT THERAPEUTICS INC ownership

SUMMIT THERAPEUTICS INC's ticker is SMMT and the CUSIP is 86627T108. A total of 59 filers reported holding SUMMIT THERAPEUTICS INC in Q4 2022. The put-call ratio across all filers is 1.29 and the average weighting 0.0%.

Quarter-by-quarter ownership
NORTHERN TRUST CORP ownership history of SUMMIT THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$1,998,093
-22.7%
1,068,499
+3.7%
0.00%
Q2 2023$2,585,405
+2117.2%
1,030,042
+1445.8%
0.00%
Q1 2023$116,608
-45.7%
66,633
+32.0%
0.00%
Q4 2022$214,600
+694.8%
50,494
+120.5%
0.00%
Q3 2022$27,000
-93.7%
22,903
-87.0%
0.00%
Q1 2022$431,000
-16.8%
175,682
-8.9%
0.00%
Q4 2021$518,000
-46.7%
192,802
-0.7%
0.00%
Q3 2021$972,000
+279.7%
194,066
+466.5%
0.00%
Q2 2021$256,00034,2550.00%
Other shareholders
SUMMIT THERAPEUTICS INC shareholders Q4 2022
NameSharesValueWeighting ↓
Alpine Global Management, LLC 202,928$8620.29%
AWM Investment Company, Inc. 300,000$1,275,0000.18%
Virtus ETF Advisers LLC 42,835$182,0490.10%
Baker Brothers Advisors 2,000,000$8,500,0000.05%
VANCE WEALTH, INC. 13,299$56,5210.04%
Inscription Capital, LLC 17,000$72,2500.02%
BOOTHBAY FUND MANAGEMENT, LLC 221,205$940,1210.02%
Steward Partners Investment Advisory, LLC 305,000$1,296,2500.02%
LEVIN CAPITAL STRATEGIES, L.P. 39,176$166,4980.02%
683 Capital Management, LLC 50,838$216,0620.02%
View complete list of SUMMIT THERAPEUTICS INC shareholders